Earnings Call · Q1 FY2021·2020-11-12

Q1 21EPS +27.27%·Rev n/aQ4 20EPS +42.86%·Rev n/aQ3 20EPS -100.00%*·Rev n/aQ2 20EPS +97.06%·Rev n/a⚠ consensus missing

AYTU BIOPHARMA, INC AYTU

Joshua Disbrow — Chairman and Chief Executive Officer

David Green — Chief Financial Officer

−5.8%1d on move date3d−9.7%5d−11.7%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AYTU calls or request research access.

More AYTU calls Browse calls Request research access